U.S. Drug Discovery Informatics Market Size & Outlook
U.S. drug discovery informatics market, 2018-2030 (US$M)
Related Markets
U.S. drug discovery informatics market highlights
- The U.S. drug discovery informatics market generated a revenue of USD 1,379.2 million in 2024 and is expected to reach USD 2,631.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 11.4% from 2025 to 2030.
- In terms of segment, sequence analysis platforms was the largest revenue generating service in 2024.
- Sequence Analysis Platforms is the most lucrative service segment registering the fastest growth during the forecast period.
Drug discovery informatics market data book summary
| Market revenue in 2024 | USD 1,379.2 million |
| Market revenue in 2030 | USD 2,631.5 million |
| Growth rate | 11.4% (CAGR from 2025 to 2030) |
| Largest segment | Sequence analysis platforms |
| Fastest growing segment | Sequence Analysis Platforms |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management |
| Key market players worldwide | Certara Inc Ordinary Shares, Boehringer Ingelheim, Infosys Ltd ADR, Charles River Laboratories International Inc, Eli Lilly and Co, Novo Nordisk A/S ADR, Oracle Corp, Accenture PLC Class A, Agilent Technologies Inc, Illumina Inc, Eurofins Scientific SE, Jubilant Biosys, Selvita, ChemAxon, Albany Molecular Research |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.8% of the global drug discovery informatics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. drug discovery informatics market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 2,631.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Discovery Informatics Market Scope
Drug Discovery Informatics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. drug discovery informatics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery informatics market will help companies and investors design strategic landscapes.
Sequence analysis platforms was the largest segment with a revenue share of 40.7% in 2024. Horizon Databook has segmented the U.S. drug discovery informatics market based on sequence analysis platforms, molecular modelling, docking, clinical trial data management covering the revenue growth of each sub-segment from 2018 to 2030.
U.S drug discovery informatics market is expected to grow at a considerable rate owing to presence of molecular R&D laboratories and market players that are involved in development of computational algorithms for screening and alignment of sequences, carried out in the process of target identification.
Furthermore, presence of pharmaceutical companies that require the informatic facilities for drug discovery attribute for significant market share in revenue in 2020: Conferences and drug discovery workshops carried out in this region are also attributive for revenue generation.
Reasons to subscribe to U.S. drug discovery informatics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. drug discovery informatics market databook
-
Our clientele includes a mix of drug discovery informatics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. drug discovery informatics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. drug discovery informatics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. drug discovery informatics market size, by service, 2018-2030 (US$M)
U.S. Drug Discovery Informatics Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
